Wilmont Cancer Institute is a clinical research site located in Rochester, New York, United States 14642.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Wilmont Cancer Institute has participated in 1 clinical trials.
Therapeutic areas: Gastrointestinal Cancer, Gastrointestinal Cancer Metastatic, Gastric Cancer.
Sponsors: Five Prime Therapeutics, Inc..
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Wilmont Cancer Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Wilmont Cancer Institute has 1 clinical trials on record. Their work covers Gastrointestinal Cancer, Gastrointestinal Cancer Metastatic, Gastric Cancer.
Wilmont Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.